Floatz logo

VINCRISTINE SULFATE

Childhood Mixed Cellularity Hodgkin Lymphoma

Children's Oncology GroupSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Childhood Mixed Cellularity Hodgkin Lymphoma cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Northwestern University
Phase 3BB
FILGRASTIM
National Cancer Institute (NCI)
Phase 3BB
Inno-206
National Cancer Institute (NCI)
Phase 3BB
BLEOMYCIN
City of Hope Medical Center
Phase 3BB
Ifosfamide
Northwestern University
Phase 3BB

View all 33 →

Same molecule, other indications

VINCRISTINE SULFATE is also rated in:

B-cell childhood acute lymphoblastic leukemiaDormant
A
Indicative ·
81 / 100
View asset →
diffuse large B-cell lymphomaDormant
A
Indicative ·
80 / 100
View asset →
Burkitt lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →